| Transitional Cell Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 115show all (up to 200) |
|---|
| → investigated in trials for | Pembrolizumabmonoclonal_antibody 95 trials (50 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 95 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 68 trials (36 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 68 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 50 trials (27 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 50 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal_antibody 36 trials (18 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enfortumab Vedotinadc 35 trials (27 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 34 trials (15 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal_antibody 32 trials (7 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 32 trials (14 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal_antibody 24 trials (8 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 22 trials (10 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal_antibody 19 trials (13 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 15 trials (3 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 14 trials (9 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 14 trials (8 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 14 trials (12 active) · roll-up of the cancer and its descendants | — | — | Transitional Cell Carcinoma | 14 | Observed | clinicaltrials | graph → |